Neuroendocrine Tumours: Diagnosis and Management

Yalcin, Suayib, Öberg, Kjell

  • 出版商: Springer
  • 出版日期: 2024-10-04
  • 售價: $7,940
  • 貴賓價: 9.5$7,543
  • 語言: 英文
  • 頁數: 701
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3031569679
  • ISBN-13: 9783031569678
  • 尚未上市,無法訂購

相關主題

商品描述

The second edition of this important textbook covers all aspects of neuroendocrine tumors (NETs), from epidemiology, pathological classification and evaluation, and molecular biology through to diagnostic imaging methods and therapeutic options, including the latest targeted therapies and immunotherapies. Readers will find individual discussion of each of the various types of NET: gastrointestinal, lung, and pancreatic tumors such as insulinomas, gastrinomas, glucagonomas, VIPomas, somatostatinomas, PPomas, and non-functioning pancreatic NETs, as well as medullary thyroid carcinomas, pheochromocytomas, paragangliomas, etc. In addition to NETs, endocrine tumors such as thyroid tumors and adrenocortical tumors are also covered. The contributing authors are internationally recognized experts who bring a wealth of science and experience to the subject. This book will be an invaluable source of information for practicing medical oncologists, surgeons, endocrinologists, gastroenterologists, and pathologists as well as for trainees in these fields.

商品描述(中文翻譯)

這本重要教科書的第二版涵蓋了神經內分泌腫瘤(NETs)的所有方面,從流行病學、病理分類和評估,到分子生物學,再到診斷影像方法和治療選項,包括最新的靶向治療和免疫治療。讀者將找到各種NET的個別討論:胃腸道、肺部和胰臟腫瘤,如胰島素瘤、胃泌素瘤、葡萄糖素瘤、VIP瘤、生長抑素瘤、PP瘤和非功能性胰臟NET,以及髓樣甲狀腺癌、腎上腺髓質細胞瘤、副神經節瘤等。除了NETs外,還涵蓋了甲狀腺腫瘤和腎上腺皮質腫瘤等內分泌腫瘤。貢獻作者是國際公認的專家,為這個主題帶來了豐富的科學和經驗。這本書將成為實踐中的醫學腫瘤學家、外科醫生、內分泌學家、胃腸病學家和病理學家以及這些領域的實習醫生的寶貴資訊來源。

作者簡介

Kjell Öberg is Professor of Endocrine Oncology at the Medical Faculty of Uppsala University and a former head of the Department of Endocrine Oncology, University Hospital, Uppsala. He is also Adjunct Professor of Surgery at Vanderbilt University, Nashville, Tenn., USA. Dr. Öberg is a specialist in endocrinology and internal medicine with 40 years' experience in the field of neuroendocrine tumors. He was one of the founders and coordinator of the European Neuroendocrine Tumor Network (ENET) (1995-2000), the president of ENETs 2010-2012 and is a past chairman of the Nordic Neuroendocrine Tumor Group. He has pioneered the treatment of carcinoid tumor patients with interferon and somatostatin analogs and developed assays for tumor markers such as chromogranin A and radiological procedures including specialized PET scans. Dr. Öberg has received numerous awards, including most recently the Rudbeck Medallion for excellence in research (2014), a Lifetime Achievement Awardfrom the North American Neuroendocrine Society (2014), The Swedish Endocrine Society Gold Medal for prominent research and clinical activities (2017), and a Lifetime Achievement Award from the European Neuroendocrine Tumor Society (ENETS), of which he has been Vice President since 2012.

Suayib Yalcin is a medical oncologist with a special interest in gastrointestinal cancer treatment and research who is a full professor at Hacettepe University Cancer Institute, Turkey. Dr. Yalcin has served as Director of the Hacettepe University Oncology Hospital and Head of the Hacettepe University Medical Oncology Department. He has held a variety of important posts in medical organizations, including President of Turkish Society of Medical Oncology, General Secretary of Turkish Oncology Group, and National Representative of ESMO in Turkey. Currently he is President of the Turkish Association of Cancer Research and Control and President of Hacettepe Oncology Association.He is an active member of ASCO, ESMO, EORTC, and MMOF. Dr. Yalcin has participated in many clinical cancer research projects as a steering committee member or principal investigator and serves on the editorial board of several cancer journals. He has been the conference chair of the International Gastrointestinal Cancer Conference (www.igicc2017.org) for the past 7 years. He has authored or co-authored more than 100 articles cited in Science Citation Index.

作者簡介(中文翻譯)

Kjell Öberg是瑞典烏普薩拉大學醫學院的內分泌腫瘤學教授,曾任烏普薩拉大學醫院內分泌腫瘤學部門主任。他還是美國田納西州納什維爾范德堡大學外科的兼職教授。Öberg博士是內分泌學和內科醫學專家,在神經內分泌腫瘤領域擁有40年的經驗。他是歐洲神經內分泌腫瘤網絡(ENET)(1995-2000)的創始人和協調人之一,並於2010年至2012年擔任ENETs主席,曾任北歐神經內分泌腫瘤小組主席。他開創了使用干擾素和生長抑素類似物治療類癌腫瘤患者的方法,並開發了如嗜鉻粒素A等腫瘤標記物的檢測方法,以及包括專業PET掃描在內的放射學程序。Öberg博士獲得了許多獎項,包括最近的魯德貝克獎(2014年)(研究卓越獎),北美神經內分泌學會終身成就獎(2014年),瑞典內分泌學會突出研究和臨床活動金牌獎(2017年),以及歐洲神經內分泌腫瘤學會(ENETS)終身成就獎,他自2012年以來一直擔任該組織的副主席。

Suayib Yalcin是土耳其哈塞特佩大學癌症研究所的全職教授,專注於胃腸癌治療和研究。Yalcin博士曾擔任哈塞特佩大學腫瘤醫院主任和哈塞特佩大學醫學腫瘤學系主任。他在醫學組織中擔任了多個重要職位,包括土耳其醫學腫瘤學會主席,土耳其腫瘤學小組總書記,以及ESMO在土耳其的國家代表。目前,他是土耳其癌症研究和控制協會主席和哈塞特佩腫瘤學協會主席。他是ASCO、ESMO、EORTC和MMOF的活躍成員。Yalcin博士作為指導委員會成員或主要研究者參與了許多臨床癌症研究項目,並擔任多個癌症期刊的編輯委員會成員。他在過去7年中一直擔任國際胃腸癌會議(www.igicc2017.org)的會議主席。他撰寫或合著的文章在科學引文索引中被引用了100多次。